Pharma and Medtech Response to Coronavirus

Pharma and Medtech Response to Coronavirus

COVID-19 puts the global supply chains for both pharma and medtech products under pressure. In the US, up to 80% of active pharmaceutical ingredients are sourced globally, with China and India playing critical roles. Industry executives estimate that Asia produces up to 50% of N95 masks (plus raw materials and fabrics for N95 masks manufactured elsewhere) as well as a large majority of isolation gowns.

While many pharma and medtech supply chains have been able to largely meet demand to date from existing inventory, it is critical that companies activate sophisticated analytics and scenario modelling to fully understand their supply chains and identify the top products facing potential supply issues, with a perspective on the next few months, taking into account potential more-aggressive infection scenarios.

You can read the details here.

About the author

Dr. Mariana Damova is the CEO of Mozaika, a company providing research and solutions in the field of data science, reasoning with natural language semantics, and natural human computer interfaces, creativity enhancing applications, and research infrastructures for the humanities. Previously, she was a Business development Manager and a Knowledge Management Expert specializing in ontology engineering and linked data management at a world leading technology provider. She was instrumental in the successful winning and knowledge modelling of large data integration and management projects such as the Semantic Knowledge Base for The National Archive of the United Kingdom and Research Space for the British Museum, as well as European FP7 projects such as Europeana Creative and Multisensor. Her work focuses on the design and development of data integration infrastructures which allow efficient querying, access and navigation over linked data. She has managed the building of the official experimental Europeana SPARQL endpoint holding Europeana semantic data. Mariana holds a PhD from the University of Stuttgart and teaches semantic technologies and multimedia at the New Bulgarian University in Sofia. She regularly reviews books and articles for ACM and has authored books and scientific articles in linguistics and semantic technologies. She has successfully lead international interdisciplinary teams and projects carrying technological risks, driven and managed change in engineering and operational contexts in North America and in Europe, and acquired the ability to leverage marketing requirements with knowledge intense technological solutions.

No comments

Leave a Reply

Your email address will not be published. Required fields are marked *